Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa

Published:2018-06-26 Issue:7 Volume:16 Page:523-530
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Ocheretyaner Eric R.¹²,Park Tae Eun³

Affiliation:

1. Division of Pharmacy Practice, LIU Pharmacy (Arnold & Marie Schwartz College of Pharmacy and Health Sciences), Brooklyn, NY, USA

2. Department of Pharmacy, Kings County Hospital Center, Brooklyn, NY, USA

3. Department of Pharmacy, BronxCare Health System, Bronx, NY, USA

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1489721

Reference39 articles.

1. Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

2. Centers for Disease Control and Prevention (CDC). About Antimicrobial Resistance. https://www.cdc.gov/drugresistance/about.html. Last updated April 6, 2017.

3. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin

4. Delafloxacin: design, development and potential place in therapy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic resistance and target-based technologies for drug development;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024

2. Biofilm formation: mechanistic insights and therapeutic targets;Molecular Biomedicine;2023-12-15

3. Staphylococcus Infections and Emerging Drug Resistance: A Global Concern;Journal of Medical Academics;2023-06-28

4. Efflux pump gene amplifications bypass necessity of multiple target mutations for resistance against dual-targeting antibiotic;Nature Communications;2023-06-09

5. In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus Associated with Skin and Soft Tissue Infections;Antibiotics;2023-05-12